Richard Goldstein - Net Worth and Insider Trading

Richard Goldstein Net Worth

The estimated net worth of Richard Goldstein is at least $5,250 dollars as of 2024-09-23. Richard Goldstein is the 10% Security Holder, Director, Senior Officer of Canntab Therapeutics Ltd and owns about 1,050,000 shares of Canntab Therapeutics Ltd (XCNQ:PILL) stock worth over $5,250. Details can be seen in Richard Goldstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Goldstein has not made any transactions after 2021-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard Goldstein

To

Richard Goldstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Goldstein owns 1 companies in total, including Canntab Therapeutics Ltd (XCNQ:PILL) .

Click here to see the complete history of Richard Goldstein’s form 4 insider trades.

Insider Ownership Summary of Richard Goldstein

Ticker Comapny Transaction Date Type of Owner
XCNQ:PILL Canntab Therapeutics Ltd 2021-06-04 10% Security Holder & Director & Senior Officer

Richard Goldstein Latest Holdings Summary

Richard Goldstein currently owns a total of 1 stock. Richard Goldstein owns 1,050,000 shares of Canntab Therapeutics Ltd (XCNQ:PILL) as of June 4, 2021, with a value of $5,250.

Latest Holdings of Richard Goldstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XCNQ:PILL Canntab Therapeutics Ltd 2021-06-04 1,050,000 0.01 5,250

Holding Weightings of Richard Goldstein


Richard Goldstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Goldstein has made a total of 9 transactions in Canntab Therapeutics Ltd (XCNQ:PILL) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Canntab Therapeutics Ltd is the acquisition of 24,000 shares on June 4, 2021, which cost Richard Goldstein around $23,040.

Insider Trading History of Richard Goldstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Goldstein Trading Performance

GuruFocus tracks the stock performance after each of Richard Goldstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Goldstein is -20.05%. GuruFocus also compares Richard Goldstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Goldstein within 3 months outperforms 0 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard Goldstein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard Goldstein

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Richard Goldstein Ownership Network

Ownership Network List of Richard Goldstein

No Data

Ownership Network Relation of Richard Goldstein

Insider Network Chart

Richard Goldstein Owned Company Details

What does Canntab Therapeutics Ltd do?

Who are the key executives at Canntab Therapeutics Ltd?

Richard Goldstein is the 10% Security Holder & Director & Senior Officer of Canntab Therapeutics Ltd.

Canntab Therapeutics Ltd (XCNQ:PILL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Canntab Therapeutics Ltd (XCNQ:PILL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Canntab Therapeutics Ltd (XCNQ:PILL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Canntab Therapeutics Ltd (XCNQ:PILL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Canntab Therapeutics Ltd Insider Transactions

No Available Data

Richard Goldstein Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Goldstein. Currently GuruFocus does not have mailing address information for Richard Goldstein.

Discussions on Richard Goldstein

No discussions yet.